CLARIFIED PRECISION MEDICINE AND MYRIAD GENETICS PARTNER TO ADVANCE PERSONALIZED PATIENT CARE AND TREATMENT PLANS
Partnership creates new Molecular Tumor Board with peer-to-peer service to support interpreting results from molecular tests Myriad Genetics, Inc. (NASDAQ:MYGN) TAMPA, FL, UNITED STATES, August 23, 2022 /EINPresswire.com/ -- [TAMPA, FL, August 10, …